Calcium Chloride Infusions are Not Associated with Improved Outcomes in Neonates Undergoing Cardiac Operations

Laura E Murray1, Holly Burchett1, Shahryar M Chowdhury1

  • 1Department of Pediatrics, Medical University of South Carolina, 10 McClennan Banks Drive, Charleston, SC, 29425, USA.

Pediatric Cardiology
|September 15, 2021
PubMed

Insights

Postoperative calcium chloride infusions did not improve cardiac performance in neonates after heart surgery. This study found no reduction in the need for other medications or improved patient outcomes.

Area of Science:

  • Cardiology
  • Neonatal Medicine
  • Pediatric Surgery

Background:

  • Neonatal cardiac function relies on myocardial calcium. Limited data exists on calcium chloride infusions in neonates undergoing cardiac surgery.
  • Calcium's role in supporting cardiac output in this population requires further investigation.

Purpose of the Study:

  • To determine if postoperative calcium chloride infusions reduce the need for inotropic and vasoactive medications in neonates after cardiac surgery.
  • To evaluate the impact of calcium chloride on cardiac output and patient outcomes in this cohort.

Main Methods:

  • Retrospective cohort study of neonates (≤30 days old) undergoing cardiac surgery between 06/2015 and 12/2018.
  • Patients were divided into groups receiving (calcium group) or not receiving (control group) postoperative calcium chloride infusions.
  • Primary outcome: maximum Vasoactive Inotropic Score (VIS) > 15 within 24 hours post-surgery.

Main Results:

  • No significant difference in maximum VIS > 15 between the calcium group (70%) and control group (55%; p=0.08).
  • Similar outcomes observed between groups regarding ventilation duration, enteral feeding time, hospital length of stay, and operative mortality.
  • Calcium chloride infusions did not decrease exposure to other vasoactive agents or improve outcomes.

Conclusions:

  • Postoperative calcium chloride infusions did not reduce the requirement for inotropic/vasoactive agents in neonates following cardiac surgery.
  • The use of calcium chloride infusions did not demonstrate improved clinical outcomes in this patient population.
  • Further research may be needed to clarify the role, if any, of calcium chloride in neonatal cardiac surgery care.

Related Concept Videos

Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
536
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
694
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
63
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
845
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
781
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
414